The Onco'Zine Brief

  • Home
  • The Onco'Zine Brief

The Onco'Zine Brief The Onco'Zine Brief is radio broadcast/podcast designed to empower listeners with facts about cancer. Should the patient consider a clinical trial?
(1)

Treatment decisions are absolutely critical, and often require input from the medical staff and the patient--especially for cancer and blood-related diseases. What is the patient's personal choice, and how can their oncologist, hematologist or nurse support their viewpoint? What role does pain management play in patient welfare? Are there new diagnostic techniques or treatments? The Onco'Zine Brie

f offers a new approach to sharing the latest news and information about cancer - from diagnostics to clinical trials and drug development to treatment and patient care. The programs are developed for medical specialists including oncologists and hematologists, other healthcare professionals involved in the management and care of patients with cancer, and oncology nurses, but also for cancer patients, survivors, and caregivers. For more information go to: http://www.oncozine.com.

Listen to the latest episodes of The Onco'Zine Brief
20/03/2024

Listen to the latest episodes of The Onco'Zine Brief

The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcar...

25/01/2024

From the Oncology Nursing Forum editor: “We are expanding our focus and outreach.” ONF readers can look forward to a themed issue focusing on areas of oncology nursing symptom science. Read more about what to expect from ONF in 2024 in January’s Editorial. https://bit.ly/3U56T5V

16/01/2024

Some cancers are generally more difficult to treat than others. The primary reason is that these difficult to treat cancers contain cells that are highly skilled at evading therapeutic drugs or our immune systems by disguising themselves as healthy cells. Glioblastoma, also called GBM, is a malignan...

12/12/2023

The The Onco'Zine Brief with Peter Hofland on UK Health Radio - Peter talks with Steven Spellman, Vice President and Senior Scientific Director at Center for International Blood & Marrow Transplant Research (CIBMTR). They discuss the cryopreservation of hematopoietic cell grafts on overall survival (OS) and other outcomes within 1 year after hematopoietic cell transplantation.

👉🏼 🎧 https://bit.ly/47QNWIi

With new and exciting updates about Antibody-drug Conjugates (ADCs) presented at  /    /   see our reporting, at www.adc...
23/10/2023

With new and exciting updates about Antibody-drug Conjugates (ADCs) presented at / / see our reporting, at www.adcreview.com. And for an overview of ADC in past and current (clinical) development go to the ADC drug map at https://www.adcreview.com/adc-drugmap/

ADC Drug Map » ADC Drug Map

19/10/2023

Webinar: Validating Protein Concentration of Antibody-Drug Conjugates
This live webinar on October 26, 2023 includes a 30-40 minute talk
with 15 minute Q&A
8 AM PDT/ 11 AM EDT/ 3 PM GMT

Click to Register: https://lnkd.in/d5Qrptz5

19/10/2023
REGISTER for our Upcoming Webinar: Validating Protein Concentration Determination in ADCs with SoloVPEThis live webinar ...
17/10/2023

REGISTER for our Upcoming Webinar:
Validating Protein Concentration Determination in ADCs with SoloVPE
This live webinar on October 26, 2023 includes a 30-40 minute talk
with 15 minute Q&A
8 AM PDT/ 11 AM EDT/ 3 PM GMT

Click to Register:
- https://conta.cc/3FlcYCI

10/10/2023

Time flows ever onward but in a circular motion. While no one can stop the passage of time, how you use is the foundation of whether you’re living a conscious, joyful, and or not. Every new day and each morning is a chance to reset the clock. To take what you’ve learned and put it to use in better ways. No matter what situation you’re in, there’s always something that you can do, because you and only you are responsible for your life. Every day we try and bring you the best health information out there so that YOU are able to live your best life!

https://www.spreaker.com/user/7078249/tob-itunes-Photoimmunotherapy
05/10/2023

https://www.spreaker.com/user/7078249/tob-itunes-Photoimmunotherapy

 In a new episode of The Onco'Zine Brief, Peter Hofland talks with David M. Cognetti, MD, a Professor and Chair in the Department Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia. Hofland and Cognetti talk about head and neck cancer and a novel treatment approach calle...

https://doi.org/10.14229/onco.2023.10.02.001
03/10/2023

https://doi.org/10.14229/onco.2023.10.02.001

Loneliness and depression significantly impact the psychological and physical well-being of older individuals diagnosed with cancer or hematological diseases. This paper reviews the intricate relationship between loneliness, depression, and their effects on older adults’ health outcomes. Through a...

19/09/2023

Gene therapy is emerging as a potential cure for those battling sickle cell disease, offering optimism for those affected by this debilitating condition. For this promise to be realized, however, significant barriers to access must be mitigated. In this article, we delve into challenges faced by vul...

18/09/2023

Intensity-modulated radiation therapy, also known as IMRT, should be utilized for treatment of locally advanced Non-Small Cell Lung Cancer (NSCLC) to reduce the risk of severe pulmonary toxicity and radiation exposure to the heart.

18/09/2023

Significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor.

https://conta.cc/3RlyePG
14/09/2023

https://conta.cc/3RlyePG

Validating Protein Concentration Determination in ADCs: Unveiling the SoloVPE Advantage Dear Peter, Validating Protein Concentration Determination in ADCs: Unveiling the SoloVPE Advantage ADCs com

Remember to register online by this Friday, September 15, 2023 to make the most of our final savings. As a member of ADC...
13/09/2023

Remember to register online by this Friday, September 15, 2023 to make the most of our final savings. As a member of ADC Review's network, you can register with code "ADCREVIEW10" to get 10% off your registration. Additional team discounts of up to 20% are also available.
https://conta.cc/3r3GyJr

Registration Closing Soon!     Hi Peter, Is there a hotter space within oncology R&D right now than within the ADC field? With a surplus of positive clinical readouts, record-breaking high capital col

Find ADC related news in the ADC Directory at www.adcdirectory.com - The ADC Directory is a membership driven companion ...
11/09/2023

Find ADC related news in the ADC Directory at www.adcdirectory.com - The ADC Directory is a membership driven companion to ADC Review / Journal of Antibody-drug Conjugates. Click on the link below to sign up an join the community!

The ADC Directory provides a seamless exchange of information between businesses and professionals focused on the research, development and manufacture of antibody-drug conjugates. Members have the opportunity to share reviews, articles, videos, events, products, career opportunities and more.

31/08/2023

The ADC Directory provides a seamless exchange of information between businesses and professionals focused on the research, development and manufacture of antibody-drug conjugates. Members have the opportunity to share reviews, articles, videos, events, products, career opportunities and more.

The  Brief with Peter Hofland on  -  MD, Professor & Chair in the Department Head & Neck Surgery  talks about head & nec...
25/08/2023

The Brief with Peter Hofland on - MD, Professor & Chair in the Department Head & Neck Surgery talks about head & neck & a novel treatment approach called .

👉🏼 🎧 ukhealthradio.com

While pricing controls imposed by the Inflation Reduction Act of 2022 (IRS) may appear positive for patients in the shor...
17/08/2023

While pricing controls imposed by the Inflation Reduction Act of 2022 (IRS) may appear positive for patients in the short term, and is considered a step forward in improving affordability of, and access to, innovative medical treatments, these controls may have unintended consequences on biopharmaceutical drug development programs and investments in the long term unless this pressure is offset by the opportunity to modernize the way clinical trials are conducted.

The Inflation Reduction Act of 2022 (IRA) covers new and reinstated tax laws that will affect individuals and businesses. Through IRA, President Biden delivered on his promise to lower prescription drug costs by allowing, for the first time, the U.S. Centers for Medicare & Medicaid Services (CMS) to...

07/08/2023

Listen to the The Inspire Health Podcast hosted by Dr Jason Loken on UK Health Radio - Common Law, Natural Law & Reclaiming your Birthright with Cal Washington. His personal journey through the court system to learn the aspects of law that are often “hidden” from the average person.

👉🎧 https://bit.ly/3qnOxQY

14th World ADC | October 16-19, 2023 | San Diego, CA.https://conta.cc/3XHz9er
03/08/2023

14th World ADC | October 16-19, 2023 | San Diego, CA.
https://conta.cc/3XHz9er

The 14th World ADC Returns to San Diego, CA. As the World's Largest Industry Dedicated Discussion an Network Forum Greetings! The ADC wave shows no sign of breaking with the ground-breaking approval o

09/07/2023

The The Onco'Zine Brief with Peter Hofland, PhD on UK Health Radio - Dr. Heery MD, medical oncologist with expertise in the translational & clinical development of & Dr. Verstovsek about the developments in treatment of myeloproliferative neoplasm.

https://bit.ly/3K9XFzF

The Inaugural ADC Linker & Conjugation Summit is coming to Boston, MA,  August 22 – 24, 2023.Follow the link for more in...
06/07/2023

The Inaugural ADC Linker & Conjugation Summit is coming to Boston, MA, August 22 – 24, 2023.
Follow the link for more information: https://conta.cc/44dEvk7

The Inaugural ADC Linker & Conjugation Summit is coming to Boston, MA Greetings! Investments in linker and conjugation technologies have become the single-biggest area of investments within the ADC fi

The inaugural ADC Toxicity Summit is coming to Boston, MA | July 25 – 27, 2023 | https://conta.cc/46xGFN6
03/07/2023

The inaugural ADC Toxicity Summit is coming to Boston, MA | July 25 – 27, 2023 | https://conta.cc/46xGFN6

The inaugural ADC Toxicity Summit is coming to Boston, MA Greetings! A wide therapeutic index is the goal for all ADC developers, and whilst efficacy is undeniable, toxicity remains the single biggest

18/05/2023
Help The Onco'Zine Brief -- a radio show/podcast about    ,   development, and much more -- reach a wider audience
06/04/2023

Help The Onco'Zine Brief -- a radio show/podcast about , development, and much more -- reach a wider audience

Nationally Syndicated Radio: Building audience trust for more than 5 years. | Check out 'The Onco’Zine Brief with Peter Hofland' on Indiegogo.

https://conta.cc/3maOR3G
04/04/2023

https://conta.cc/3maOR3G

“Think of ADCs as guided missiles, in which the antibody is the cancer detector andthe cytotoxin the missile’s warhead.”

Join the The Onco'Zine Brief - Affordable National Sponsorship & Advertising Opportunities Designed to Connect with 75 m...
27/03/2023

Join the The Onco'Zine Brief - Affordable National Sponsorship & Advertising Opportunities Designed to Connect with 75 million Highly Engaged Listeners

https://conta.cc/40Bq1Z5

Connect with 75 million Engaged Listeners     Connect with Engaged Listeners AFFORDABLE NATIONAL SPONSORSHIP & ADVERTISING OPPORTUNITY to 75 million people Hello Peter,   The Onco’Zine Brief® is avail

Address

AZ

Alerts

Be the first to know and let us send you an email when The Onco'Zine Brief posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The Onco'Zine Brief:

Shortcuts

  • Address
  • Telephone
  • Alerts
  • Contact The Business
  • Claim ownership or report listing
  • Want your business to be the top-listed Media Company?

Share

Our Story

Treatment decisions are absolutely critical, and often require input from the medical staff and the patient--especially for cancer and blood related diseases. What is the patient's personal choice, and how can their oncologist, hematologist or nurse support their viewpoint? Should the patient consider a clinical trial? What role does pain management play in patient welfare? Are there new diagnostic techniques or treatments? Listen live every Saturday at 1:00 p.m. PT Host: Peter Hofland. PhD and Co-host: Sonia Portillo Tune in: Independent Talk 1100 KFNX (Phoenix, AZ)

News and Information and the latest Updates

The Onco’Zine Brief offers a new approach to sharing the latest news and information about cancer - from diagnostics to clinical trials and drug development to treatment and patient care. The programs are developed for medical specialists including oncologist and hematologists, other healthcare professionals involved in the management and care of patients with cancer and oncology nurses, but also for cancer patients, their family members, cancer survivors and caregivers.

The Onco’Zine Brief on PRX (Radio about Cancer) The OncoZine Brief on PRX (Public Radio Exchange) is an interview and discussion program covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world.